XML 26 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Operating Expenses:        
Research and development $ 355,051 $ 159,926 $ 590,815 $ 417,471
Research and development - related party 12,500 50,000 47,975 111,667
General and administrative 627,548 693,405 1,477,665 1,107,525
Total Operating Expenses 995,099 903,331 2,116,455 1,636,663
Loss From Operations (995,099) (903,331) (2,116,455) (1,636,663)
Other (Expense) Income:        
Interest expense (140,305) (81,164) (396,688) (157,647)
Interest expense - related parties (22,540) (12,715) (47,044) (23,881)
Amortization of debt discount (155,169) (36,228) (277,932) (44,530)
Change in fair value of derivative liabilities 16,977
Gain on forgiveness of accrued interest 49,983
Loss on extinguishment of notes payable (131,250) (49,718) (132,691)
Total Other Expense (318,014) (261,357) (721,399) (341,772)
Net Loss (1,313,113) (1,164,688) (2,837,854) (1,978,435)
Dividend attributable to Series A preferred stockholders (225,873) (211,885) (449,264) (423,190)
Net Loss Applicable to Common Stockholders $ (1,538,986) $ (1,376,573) $ (3,287,118) $ (2,401,625)
Net Loss Per Common Share - Basic and Diluted $ (0.05) $ (0.05) $ (0.10) $ (0.08)
Weighted Average Common Shares Outstanding -        
Basic and Diluted 32,663,482 30,020,692 32,610,275 29,570,645